Siemens Healthineers opening logistics depots in US to boost inventory

Expanding parts inventory and logistics capabilities will support later cutoff times, same-day delivery within 300 miles and more next-flight-out options for customers, the company said.

By Nick Paul Taylor • Feb. 20, 2025

Device industry scrambles as FDA job cuts cause delays

The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an attorney said.

By Elise Reuter • Feb. 20, 2025

Explore the Trendline➔

Medical device industry continues to turn to AI

While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.

By MedTech Dive staff

Advamed CEO warns FDA job cuts put patients, industry at risk

Scott Whitaker sent a letter to the HHS calling for staff cuts at the FDA to be reversed, arguing patient care and U.S. leadership in medtech are on the line.

By Susan Kelly • Feb. 19, 2025

Vicarious Surgical COO John Mazzola to retire

Mazzola’s retirement plan comes less than two months after CFO William Kelly left the surgical robot developer.

By Susan Kelly • Feb. 19, 2025

Medtech firms have little to say on Trump tariffs

Wall Street analysts said current tariffs should be “manageable” for the sector but cautioned that other countries may retaliate.

By Elise Reuter • Feb. 19, 2025

Philips expects sales struggles in China to continue in 2025

Philips forecast a double-digit sales decline in China for the first half of 2025 after reporting “significant deterioration” of demand in October.

By Nick Paul Taylor • Feb. 19, 2025

J&J resumes PFA cases, but analysts warn safety may hamper rollout

J.P. Morgan analysts said the findings of J&J’s investigation “could significantly hinder the product’s rollout in the U.S. and globally” and lead doctors to “de-prioritize Varipulse.”

By Nick Paul Taylor • Feb. 18, 2025

Mitigating tariffs: EY’s Lynlee Brown discusses strategies for medtech

Lynlee Brown, a global trade partner at EY, outlined several strategies for device manufacturers to offset fast-moving tariffs.

By Elise Reuter • Feb. 18, 2025

Medtronic buys Nanovis’ nano technology for use in spine implants

Medtronic will use the technology to develop PEEK interbody spine fusion devices that enhance implant fixation.

By Nick Paul Taylor • Feb. 13, 2025

Judge orders FDA, health agencies to restore removed webpages

District Judge John Bates wrote the removals harm “everyday Americans, and most acutely, underprivileged Americans, seeking healthcare.”

By Elise Reuter • Feb. 12, 2025

Edwards predicts second-half lift from TAVR label expansion

Executives expect a new label indication and a hoped-for easing of hospital capacity constraints to accelerate sales this year.

By Susan Kelly • Feb. 12, 2025

How Trump’s trade fight could impact the medtech industry

Relocating manufacturing would require substantial capital investment, but the timespan for the president’s new tariffs is unclear, supply chain experts said.

By Susan Kelly • Feb. 12, 2025

EMA creates advice portal for some high-risk medical devices

The European Medicines Agency said the portal will enable consultations with medical device expert panels that can promote faster access to new technologies. 

By Nick Paul Taylor • Feb. 12, 2025

Inspire Medical reveals DOJ civil investigation

CEO Tim Herbert told investors the company received a civil investigative demand from the Department of Justice in January for information on marketing and reimbursement practices.

By Ricky Zipp • Feb. 11, 2025

Mass General Brigham to conduct largest layoffs in its history

MGB said the layoffs were necessary to get ahead of an anticipated budget shortfall of $250 million over the next two years.

By Susanna Vogel • Feb. 11, 2025

Former FDA head Gottlieb calls for less regulation of certain AI tools

Gottlieb, who led the agency during the first Trump presidency, supports a reversion to an earlier interpretation of the 21st Century Cures Act.

By Elise Reuter • Feb. 11, 2025

M&A and a separation take center stage in latest earnings season

BD announced it would split from its biosciences and diagnostics unit, while Zimmer Biomet updated investors on its $1.1 billion buy of Paragon 28.

By Susan Kelly • Feb. 10, 2025

FDA posts early alert about BD device linked to 30 injuries, 4 deaths

The alert was posted one day after BD sent customers a letter warning about the risk of atherectomy catheters breaking.

By Nick Paul Taylor • Feb. 10, 2025

Thermo Fisher lays off another 300 workers in Massachusetts

Job cuts in Cambridge and Plainville are the second workforce reduction planned for the facilities in the past three months.

By Susan Kelly • Feb. 7, 2025

BD plans split from life science business to fuel medtech investment

CEO Tom Polen said BD will “double down on shifting our portfolio, both organically and inorganically through tuck-in M&A, into higher-growth, high-margin accretive growth spaces.”

By Nick Paul Taylor • Feb. 7, 2025

Globus to buy Nevro for $250M

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale and orthopedic relationships.

By Elise Reuter • Feb. 6, 2025

Zimmer touts ASC opportunity with Paragon 28 purchase

With the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, extremities and trauma segment will outpace hips and knees.

By Elise Reuter • Feb. 6, 2025

Medtronic’s Orleigh Bogle on changing the culture of surgical training

Bogle, Medtronic’s head of medical affairs for digital surgery, also discussed the company’s plans to train surgeons for its Hugo surgical robot.

By Elise Reuter • Feb. 6, 2025

AHA joins call for Trump to exempt devices from import tariffs

Disruption to the supply of devices from China would curtail hospitals' ability to perform life-saving surgeries and protect patients and healthcare workers from contagion, the group warned.

By Nick Paul Taylor • Feb. 6, 2025

Pulse Biosciences names new CFO, continuing string of C-suite changes

Pulse, which named a new CEO last month, is pitching its pulsed field ablation technology as a way to shorten procedure times.

By Nick Paul Taylor • Feb. 5, 2025